Literature DB >> 9849338

Current practice in primary total hip replacement: results from the National Hip Replacement Outcome Project.

A J Best1, D Fender, W M Harper, A W McCaskie, K Oliver, P J Gregg.   

Abstract

As part of the National Study of Primary Hip Replacement Outcome, 402 consultant orthopaedic surgeons from three regions were contacted by postal questionnaire which covered all aspects of total hip replacement (THR). There was a 70% response rate of which 71 did not perform hip surgery, a further 33 refused to take part, leaving 181 valid responses. Preoperative assessment clinics were used by 89% of surgeons, but anaesthetists and rehabilitation services were rarely involved at this stage. Of respondents, 99% used routine thromboprophylaxis, with 79% using a combination of mechanical and chemical methods. Of surgeons, 84% routinely used stockings, whereas 95.5% used chemical prophylaxis, 63% employed low molecular weight heparins. Theatre facilities were shared with other surgical specialties by 6% of surgeons and 18% regularly used body exhaust suits for THR. Antibiotic loaded cement was used by 69% of surgeons, the majority (65%) used a single brand of normal viscosity cement with 9% using reduced viscosity formulations. Modern cementing techniques were commonly used at least in part, 87% used a cement gun and 94% a cement restrictor for femoral cementing. On the acetabulum, 47% pressurised the cement. In all, 36 different femoral stems and 35 acetabular cups were in routine use, but the majority of surgeons (55%) used Charnley type prostheses. Of the surgeons, 57% performed only cemented THR, while 3% exclusively used uncemented THR. Of consultants, 21% followed up their patients to 5 years, the majority discharge patients within the first year. Of concern is a large proportion of surgeons using low molecular weight heparins despite a lack of evidence with regard to reducing fatal pulmonary embolism, and also the small number of surgeons using prostheses of unproven value. Third generation cementing techniques have yet to be fully adopted. The introduction of a national hip register could help to resolve some of these issues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849338      PMCID: PMC2503116     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  18 in total

1.  Total hip replacement and antithrombotic prophylaxis.

Authors:  I J Brenkel; M J Clancy
Journal:  Br J Hosp Med       Date:  1989-10

2.  Major orthopaedic surgery on the leg and thromboembolism.

Authors:  J Parker-Williams; R Vickers
Journal:  BMJ       Date:  1991-09-07

3.  Orthopaedic surgeons and thromboprophylaxis.

Authors:  M D Laverick; S A Croal; R A Mollan
Journal:  BMJ       Date:  1991-09-07

4.  Current UK opinion on thromboprophylaxis in orthopaedic surgery: its use in routine total hip and knee arthroplasty.

Authors:  A J Unwin; J R Jones; W J Harries
Journal:  Ann R Coll Surg Engl       Date:  1995-09       Impact factor: 1.891

Review 5.  Which primary total hip replacement?

Authors:  D W Murray; A J Carr; C J Bulstrode
Journal:  J Bone Joint Surg Br       Date:  1995-07

Review 6.  Graduated compression stockings in the prevention of postoperative deep vein thrombosis.

Authors:  P C Jeffery; A N Nicolaides
Journal:  Br J Surg       Date:  1990-04       Impact factor: 6.939

7.  Current attitudes to cementing techniques in British hip surgery.

Authors:  A Hashemi-Nejad; N C Birch; N J Goddard
Journal:  Ann R Coll Surg Engl       Date:  1994-11       Impact factor: 1.891

8.  Total hip replacement without deep infection in a standard operating room.

Authors:  D K Collis; K Steinhaus
Journal:  J Bone Joint Surg Am       Date:  1976-06       Impact factor: 5.284

9.  Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement.

Authors:  A C Hui; C Heras-Palou; I Dunn; P D Triffitt; A Crozier; J Imeson; P J Gregg
Journal:  J Bone Joint Surg Br       Date:  1996-07

10.  Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors.

Authors:  O M Lidwell; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  J Hyg (Lond)       Date:  1984-12
View more
  6 in total

1.  Revision hip arthroplasty activity in a single UK health region: an audit of 1265 cases.

Authors:  T Hassan; S Birtwistle; R A Power; W M Harper
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

2.  Femoral cementing techniques: current trends in the UK.

Authors:  S K Nedungayil; S Mehendele; S Gheduzzi; I D Learmonth
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

3.  Are national guidelines for total hip replacement in the UK reflected in practice?

Authors:  A Abraham; L Hajipour; A R Innes; H Phillips; A W McCaskie
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

4.  Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo.

Authors:  Xiaoyun Pan; Xin Mao; Tao Cheng; Xianlong Zhang
Journal:  Mol Cell Biochem       Date:  2011-05-29       Impact factor: 3.396

5.  Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor.

Authors:  M H A Malik; F Jury; A Bayat; W E R Ollier; P R Kay
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

6.  Prophylactic use of antibiotic-loaded bone cement in primary total knee arthroplasty: Justified or not?

Authors:  Amit K Srivastav; Biren Nadkarni; Shekhar Srivastav; Vivek Mittal; Shekhar Agarwal
Journal:  Indian J Orthop       Date:  2009-07       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.